I'm not an expert in this space at all, but I did want to let you know about some research we have funded through CIHR, about $35 million in funding towards ovarian cancer research in the past five years. This research focuses on projects that look at point-of-care testing devices, so there's recognition there around point of care, meaning perhaps increased accessibility for those who are living outside of urban areas, improving detection and diagnosis, and, of course, treatment.
In particular, there is a large project that is going on at UBC with Dr. Samuel Aparicio working on detection in that space. Again, it's research that's under way. As Dr. Kaida mentioned in her response to an earlier question, we will be paying attention to that research as the results come out in order to implement them into care.
Thank you.